Skip to main content
Caplight Logo









i-Lumen Scientific

i-Lumen Scientific

Private
Bloomington, MinnesotaHealthcare & Life Scienceshttps://www.i-lumen.com/

Last Round

Series B

Dec 16, 2025

Est. Valuation

$49.5M

Total Funding Raised

$44.6M

Company Overview

i-Lumen Scientific is a medical device company that develops non-invasive transpalpebral microcurrent electrical stimulation technology to treat vision loss caused by dry age-related macular degeneration.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

age-related macular degenerationAMDbioelectric stimulationmicrocurrent stimulationophthalmic medical deviceretinal therapybioelectronic medicinenon-invasive ophthalmologytranspalpebral stimulationeye care technologyusage-based billingmedical device consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

i-Lumen Scientific Comparables

Compare i-Lumen Scientific with similar companies based on industry and business-model similarity.

i-Lumen Scientific comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MacuMira Medical Devices Inc
87%
Nova Oculus Medical
86%
SYSTANE
84%

i-Lumen Scientific Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 16, 2025
Series BDec 27, 2022
Series A ExtensionNov 15, 2022
Series ASep 30, 2021
Series AJul 30, 2020

i-Lumen Scientific Investors

Notable investors and investment history

i-Lumen Scientific investors
InvestorRounds
K2X CapitalSeries B
Alafi CapitalSeries B
Santen VenturesSeries B
Bios PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2026

    Executing i-LUMEN™ system trial with operations in US and Australia.

  • Sep 30, 2021

    $4M round completed.

i-Lumen Scientific Filings

Explore SEC and related filing metadata, where available.

i-Lumen Scientific filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about i-Lumen Scientific's valuation, stock price, and market status.

Is i-Lumen Scientific a public or private company?

i-Lumen Scientific is a private company.

What is the current stock price of i-Lumen Scientific?

i-Lumen Scientific is a private company with no public stock price. No recent secondary market data is available.

How much is i-Lumen Scientific worth (valuation)?

i-Lumen Scientific's valuation is estimated at $57.6M based on funding round data.

Can I buy i-Lumen Scientific stock?

i-Lumen Scientific shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was i-Lumen Scientific's last funding round?

i-Lumen Scientific's most recent funding round was Series B on September 30, 2025.

Who are the main investors in i-Lumen Scientific?

Investor information for i-Lumen Scientific is not publicly disclosed.

Will i-Lumen Scientific IPO soon?

No public IPO plans have been announced for i-Lumen Scientific.

How can I track i-Lumen Scientific secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor i-Lumen Scientific's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBloomington, Minnesota
Employee Range7
Year Founded2015
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?